|
Tamara New, M.D. is the Director of the Comprehensive Sickle Cell Center at Harlem Hospital Center in New York, NY. Dr. New also holds other leadership positions at Harlem Hospital Center, including Director of the Pediatric Residency Program, Director of the Pediatric Hematology-Oncology of Harlem Hospital Center and Clinical Director of the third year medical student Pediatric Clerkship program. She has been an Assistant Professor of Pediatrics in the Department of Pediatric Oncology at Children’s Hospital of New York, Presbyterian Hospital, Columbia University since 2002. Dr. New did her residency in Pediatrics at UMDNJ - Robert Wood Johnson University Hospital in New Brunswick, NJ, one of the five hospitals that have committed to participating in Xechem’s FDA clinical trials. She belongs to several professional organizations, including American Society of Pediatric Hematology-Oncology, Sickle Cell Advisory Committee and American Society of Hematology. She has lectured on Sickle Cell Anemia at Harlem Hospital Center and Abyssinian Baptist Church. Dr. New was recognized at the press conference held by United States Senator Charles Schumer at Harlem Hospital Center in October 2003 to announce his support of the Sickle Cell Treatment Act of 2003 (passed into law in 2004), during which the rising rates of Sickle Cell Disease in central Harlem were discussed. Dr. New obtained her Doctor of Medicine degree from Mount Sinai School of Medicine, New York, NY and her BA in Chemistry from Smith College, Northampton, MA.
| 